126 related articles for article (PubMed ID: 11693802)
1. Adjuvant radiochemotherapy in high-risk rectal cancer results of a prospective non-randomized study.
Lupattelli M; Maranzano E; Bellavita R; Tarducci R; Latini R; Castagnoli P; Bufalari A; Corgna E; Pinaglia D; Rossetti R; Ribacchi R; Latini P
Tumori; 2001; 87(4):239-47. PubMed ID: 11693802
[TBL] [Abstract][Full Text] [Related]
2. [Adjuvant radio-chemotherapy in cancer of the rectum treated with radical surgery and with high risk of recurrence. Preliminary results of a prospective study].
Lupattelli M; Maranzano E; Trancanelli V; Belsanti V; Pinaglia D; Beneventi S; Latini P
Radiol Med; 1998; 95(1-2):86-92. PubMed ID: 9636733
[TBL] [Abstract][Full Text] [Related]
3. Raltitrexed and radiotherapy as adjuvant treatment for stage II-III rectal cancer: a feasibility study.
Lupattelli M; Maranzano E; Bellavita R; Natalini G; Corgna E; Rossetti R; Trippa F; Mascioni F; Sidoni A; Anselmo P; Buzzi F; Brugia M; Latini P
Tumori; 2005; 91(6):498-504. PubMed ID: 16457149
[TBL] [Abstract][Full Text] [Related]
4. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer. A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94).
Sauer R; Fietkau R; Wittekind C; Martus P; Rödel C; Hohenberger W; Jatzko G; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R
Strahlenther Onkol; 2001 Apr; 177(4):173-81. PubMed ID: 11370551
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant vs. neoadjuvant radiochemotherapy for locally advanced rectal cancer: the German trial CAO/ARO/AIO-94.
Sauer R; Fietkau R; Wittekind C; Rödel C; Martus P; Hohenberger W; Tschmelitsch J; Sabitzer H; Karstens JH; Becker H; Hess C; Raab R;
Colorectal Dis; 2003 Sep; 5(5):406-15. PubMed ID: 12925071
[TBL] [Abstract][Full Text] [Related]
7. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
8. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
9. The postoperative adjuvant radiation therapy and radiochemotherapy for UICC stage II and III rectal cancer. A retrospective analysis.
Bagatzounis A; Willner J; Oppitz U; Flentje M
Strahlenther Onkol; 2000 Mar; 176(3):112-7. PubMed ID: 10742831
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group.
Tveit KM; Guldvog I; Hagen S; Trondsen E; Harbitz T; Nygaard K; Nilsen JB; Wist E; Hannisdal E
Br J Surg; 1997 Aug; 84(8):1130-5. PubMed ID: 9278661
[TBL] [Abstract][Full Text] [Related]
11. Preoperative radiation with concurrent 5-fluorouracil for locally advanced T4-primary rectal cancer.
Rödel C; Grabenbauer GG; Schick C; Papadopoulos T; Hohenberger W; Sauer R
Strahlenther Onkol; 2000 Apr; 176(4):161-7. PubMed ID: 10812388
[TBL] [Abstract][Full Text] [Related]
12. [The acute toxicity of the simultaneous radiochemotherapy of rectal carcinoma].
Rödel C; Fietkau R; Keilholz L; Grabenbauer GG; Kessler H; Martus P; Sauer R
Strahlenther Onkol; 1997 Aug; 173(8):415-21. PubMed ID: 9289858
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant-intensified treatment for rectal cancer: time to change?
Musio D; De Felice F; Bulzonetti N; Guarnaccia R; Caiazzo R; Bangrazi C; Raffetto N; Tombolini V
World J Gastroenterol; 2013 May; 19(20):3052-61. PubMed ID: 23716984
[TBL] [Abstract][Full Text] [Related]
14. Intermittent use of amifostine during postoperative radiochemotherapy and acute toxicity in rectal cancer patients.
Dunst J; Semlin S; Pigorsch S; Müller AC; Reese T
Strahlenther Onkol; 2000 Sep; 176(9):416-21. PubMed ID: 11050915
[TBL] [Abstract][Full Text] [Related]
15. Anemia and long-term outcome in adjuvant and neoadjuvant radiochemotherapy of stage II and III rectal adenocarcinoma: the Freiburg experience (1989-2002).
Weissenberger C; Geissler M; Otto F; Barke A; Henne K; von Plehn G; Rein A; Muller C; Bartelt S; Henke M
World J Gastroenterol; 2006 Mar; 12(12):1849-58. PubMed ID: 16609990
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radio-chemotherapy in stage II-III rectal cancer with 24-hour infusion of high-dose 5-fluorouracil and folinic acid: evaluation of feasibility.
Dencausse Y; Sturm J; Hartung G; Dietzler P; Edler L; Bambach M; Wojatschek C; Lindemann H; Qeisser W
Onkologie; 2001 Oct; 24(5):476-80. PubMed ID: 11694775
[TBL] [Abstract][Full Text] [Related]
17. Five fractions of preoperative radiotherapy for selected cases of rectal carcinoma: long-term tumor control and tolerance to treatment.
Myerson RJ; Genovesi D; Lockett MA; Birnbaum E; Fleshman J; Fry R; Kodner I; Menteer J; Picus J; Read T; Walz B
Int J Radiat Oncol Biol Phys; 1999 Feb; 43(3):537-43. PubMed ID: 10078634
[TBL] [Abstract][Full Text] [Related]
18. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer.
Wichmann MW; Müller C; Meyer G; Strauss T; Hornung HM; Lau-Werner U; Angele MK; Schildberg FW
Arch Surg; 2002 Feb; 137(2):206-10. PubMed ID: 11822961
[TBL] [Abstract][Full Text] [Related]
19. Preoperative radiotherapy and concurrent chemotherapy with bolus 5-fluorouracil for rectal cancer: a prospective analysis of 98 patients.
Wygoda M; Rottenberg Y; Kadouri L; Pikarsky A; Hubert A
Tumori; 2010; 96(5):709-12. PubMed ID: 21302617
[TBL] [Abstract][Full Text] [Related]
20. Monthly tegafur-uracil maintenance for increasing relapse-free survival in ypStage III rectal cancer patients after preoperative radiotherapy, radical resection, and 12 postoperative chemotherapy cycles: a retrospective study.
Kuo YH; Lai CH; Huang CY; Chen CJ; Huang YC; Huang WS; Chin CC
BMC Cancer; 2019 Aug; 19(1):815. PubMed ID: 31419963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]